J Cardiovasc Electrophysiol. 2026 Aug 30. doi: 10.1111/jce.70484. Online ahead of print.ABSTRACTINTRODUCTION: Diagnosis and treatment of children and adolescents with suspected Brugada syndrome (BrS) is challenging. Aim of the study was to evaluate the applicability of current diagnostic criteria fo
Adv Sci (Weinh). 2026 Aug 30:e77379. doi: 10.1002/advs.77379. Online ahead of print.ABSTRACTBACKGROUND: Cardiac fibrosis is a central driver of adverse remodeling and heart failure (HF), yet effective antifibrotic therapies remain limited. SerpinA3, a member of the serine protease inhibitor family,
CNS Neurosci Ther. 2026 Sep;32(9):e71116. doi: 10.1002/cns.71116.ABSTRACTAIMS: To preliminarily characterize metabolic molecular subtypes of cerebral thromboemboli and evaluate their clinical significance in anterior circulation acute ischemic stroke due to large vessel occlusion (AIS-LVO).METHODS:
Eur Heart J. 2026 Aug 30:ehag736. doi: 10.1093/eurheartj/ehag736. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Healthcare professionals (HCPs) play a central role in preventive care, yet their own cardiovascular health management remains poorly characterised. We evaluated cardiovascular risk p
No abstractEur J Heart Fail. 2026 Aug 30:xuag269. doi: 10.1093/ejhf/xuag269. Online ahead of print.NO ABSTRACTPMID:42669130 | DOI:10.1093/ejhf/xuag269
Eur J Prev Cardiol. 2026 Aug 30:zwag282. doi: 10.1093/eurjpc/zwag282. Online ahead of print.ABSTRACTObservational studies and intervention trials provide the evidence base for developing strategies for primary and secondary prevention of cardiovascular disease (CVD). The Joint European Society of Ca
No abstractEur Heart J. 2026 Aug 30:ehag694. doi: 10.1093/eurheartj/ehag694. Online ahead of print.NO ABSTRACTPMID:42669127 | DOI:10.1093/eurheartj/ehag694
Circ Popul Health Outcomes. 2026 Aug 30:e013883. doi: 10.1161/CIRCOUTCOMES.126.013883. Online ahead of print.ABSTRACTBACKGROUND: Although the effectiveness of Lp(a) (lipoprotein[a])-lowering therapies remains under study, lipid guidelines now recommend Lp(a) testing in all adults to identify individ
Int J Cardiovasc Imaging. 2026 Aug 30. doi: 10.1007/s10554-026-03804-8. Online ahead of print.ABSTRACTThe ramus intermedius (RI) is a variant artery arising from the trifurcation of the left main (LM) coronary artery. While prior work from our group has demonstrated that RI is associated with greate
Eur J Nucl Med Mol Imaging. 2026 Aug 30. doi: 10.1007/s00259-026-08135-3. Online ahead of print.ABSTRACTRATIONALE: The time-dependent contributions of coronary atherosclerotic plaque burden and myocardial ischemia to clinical outcomes in suspected coronary artery disease (CAD) remain uncertain. This
Cardiovasc Res. 2026 Aug 30:cvag173. doi: 10.1093/cvr/cvag173. Online ahead of print.ABSTRACTAIMS: Adherence with a holistic or integrated care management of atrial fibrillation (AF) based on the AF better care (ABC) pathway has been associated with improved clinical outcomes. Two prospective random
Biomech Model Mechanobiol. 2026 Aug 30;25(5):96. doi: 10.1007/s10237-026-02119-w.ABSTRACTPremature ventricular complexes (PVCs) are common cardiac arrhythmias that can lead to cardiomyopathy when frequent. Post-extrasystolic potentiation (PESP), which is the transient increase in contractility follo
JACC Heart Fail. 2026 Aug 30:103366. doi: 10.1016/j.jchf.2026.103366. Online ahead of print.ABSTRACTBACKGROUND: Safe and effective decongestion remains an important therapeutic goal in patients hospitalized for heart failure.OBJECTIVES: The authors evaluated the effect of dapagliflozin on multiple c
No abstractJ Am Coll Cardiol. 2026 Aug 30:S0735-1097(26)07376-6. doi: 10.1016/j.jacc.2026.08.007. Online ahead of print.NO ABSTRACTPMID:42669072 | DOI:10.1016/j.jacc.2026.08.007
J Am Coll Cardiol. 2026 Aug 5:S0735-1097(26)07209-8. doi: 10.1016/j.jacc.2026.07.023. Online ahead of print.ABSTRACTBACKGROUND: Vutrisiran, an RNA interference therapeutic, reduced all-cause mortality and recurrent cardiovascular events in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Biomarkers. 2026 Aug 30:1-13. doi: 10.1080/1354750X.2026.2726961. Online ahead of print.ABSTRACTBACKGROUND: C-reactive protein (CRP) is a biomarker of vascular inflammation with prognostic value for future cardiovascular events. This meta-analysis investigates the effect of colchicine, a cheap and w
JAMA. 2026 Aug 30. doi: 10.1001/jama.2026.17246. Online ahead of print.ABSTRACTIMPORTANCE: Gene-silencing therapies reduce hepatic transthyretin (TTR) production and have been evaluated in phase 3 trials in TTR amyloid cardiomyopathy (ATTR-CM). However, differences in trial design and background the
Eur Heart J Qual Care Clin Outcomes. 2026 Aug 30:qcag139. doi: 10.1093/ehjqcco/qcag139. Online ahead of print.ABSTRACTBACKGROUND: Whether COVID-19 vaccination is associated with lower long-term cardiovascular risk after SARS-CoV-2 infection and how much infection prevention mediates this association
Eur Heart J Cardiovasc Imaging. 2026 Aug 30:jeag205. doi: 10.1093/ehjci/jeag205. Online ahead of print.ABSTRACTAIMS: Right atrial pressure (RAP) is a key determinant of right-sided heart function and guides diagnosis and management across a wide range of cardiovascular diseases. However, reliable no
Eur Heart J. 2026 Aug 30:ehag729. doi: 10.1093/eurheartj/ehag729. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Hypertension is a common attributable cause of chronic kidney disease (CKD). Mineralocorticoid receptor overactivation can lead to hypertension and contributes to CKD progression. In
Europace. 2026 Aug 4;28(8):euag214. doi: 10.1093/europace/euag214.ABSTRACTAIMS: Population-based screening for atrial fibrillation (AF) should be considered in elderly individuals to enable AF detection. However, participation in systematic screening programmes is often suboptimal. STROKESTOP III ev
Europace. 2026 Aug 4;28(8):euag140. doi: 10.1093/europace/euag140.ABSTRACTAIMS: Conventional screening modalities for atrial fibrillation (AF) are often constrained by considerable resource and logistical demands. The randomized controlled NORwegian atrial fibrillation self-SCREENing (NORSCREEN) tri
Europace. 2026 Aug 4;28(8):euag184. doi: 10.1093/europace/euag184.ABSTRACTVery rare and ultra-rare primary inherited arrhythmia syndromes (IAS) represent a heterogeneous group of disorders associated with a significant risk of sudden cardiac death, often manifesting from foetal life to early adultho
Europace. 2026 Aug 4;28(8):euag153. doi: 10.1093/europace/euag153.ABSTRACTMyocarditis is an important and frequently underrecognized cause of atrioventricular conduction disease and ventricular arrhythmias and may also be associated with atrial arrhythmias and sinus node dysfunction. Arrhythmic risk
